{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T11:29:04Z","timestamp":1750937344733},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T00:00:00Z","timestamp":1572220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s00120-019-01055-1","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T11:09:37Z","timestamp":1572260977000},"page":"1353-1360","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Verbesserung der Impft\u00e4tigkeiten in der Urologie"],"prefix":"10.1007","volume":"58","author":[{"given":"Peter","family":"Schneede","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,28]]},"reference":[{"key":"1055_CR1","unstructured":"https:\/\/www.who.int\/emergencies\/ten-threats-to-global-health-in-2019\n                    \n                   Zugeriffen: 02. April 2019"},{"key":"1055_CR2","unstructured":"https:\/\/www.rki.de\/DE\/Content\/Kommissionen\/STIKO\/Empfehlungen\/Aktuelles\/Impfkalender_Poster_dt.pdf?_bolb=publicationFile\n                    \n                  . Zugegriffen: 05.April 2019"},{"key":"1055_CR3","first-page":"79","volume-title":"Der Impfkurs","author":"W Jilg","year":"2018","unstructured":"Jilg\u00a0W (2018) Die Impfung gegen Tetanus. In: Jilg\u00a0W (Hrsg) Der Impfkurs. Ecomed MEDIZIN, Landsberg am Lech, S\u00a079\u201385"},{"key":"1055_CR4","unstructured":"Tetanus vaccines: WHO position paper\u2014February 2017 (2017) Wkly Epidemiol Rec. 92: 53\u201376"},{"key":"1055_CR5","first-page":"92","volume-title":"Der Impfkurs","author":"W Jilg","year":"2018","unstructured":"Jilg\u00a0W (2018) Die Impfung gegen Pertussis (Keuchhusten). In: Jilg\u00a0W (Hrsg) Der Impfkurs. Ecomed MEDIZIN, Landsberg am Lech, S\u00a092\u201398"},{"key":"1055_CR6","first-page":"99","volume-title":"Der Impfkurs","author":"W Jilg","year":"2018","unstructured":"Jilg\u00a0W (2018) Die Impfung gegen Poliomyelitis (Kinderl\u00e4hmung). In: Jilg\u00a0W (Hrsg) Der Impfkurs. Ecomed MEDIZIN, Landsberg am Lech, S\u00a099\u2013107"},{"key":"1055_CR7","first-page":"541","volume":"50","author":"STIKO (St\u00e4ndige Impfkommission am Robert Koch-Institut)","year":"2018","unstructured":"STIKO (St\u00e4ndige Impfkommission am Robert Koch-Institut) (2018) Wissenschaftliche Begr\u00fcndung zur Empfehlung einer Impfung mit dem Herpes zoster-subunit-Totimpfstoff. Epidemiol Bull 50:541\u2013567","journal-title":"Epidemiol Bull"},{"key":"1055_CR8","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s00120-017-0394-4","volume":"56","author":"P Schneede","year":"2017","unstructured":"Schneede\u00a0P (2017) Ein Jahrzehnt der HPV-Impfung in Deutschland. Urologe 56:728\u2013733","journal-title":"Urologe"},{"key":"1055_CR9","first-page":"A1382","volume":"115","author":"SJ Klug","year":"2018","unstructured":"Klug\u00a0SJ, Meerpohl\u00a0J, R\u00f6bl-Mathieu\u00a0M et al (2018) HPV-Impfung. Auch Jungen k\u00f6nnen profitieren. Dtsch Arztebl 115:A1382\u2013A1386","journal-title":"Dtsch Arztebl"},{"key":"1055_CR10","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1007\/s00120-018-0793-1","volume":"57","author":"SJ Klug","year":"2018","unstructured":"Klug\u00a0SJ, van der Sande\u00a0M, Terhardt\u00a0M et al (2018) Die STIKO empfiehlt die HPV-Impfung jetzt auch f\u00fcr Jungen. Urologe 57:1346\u20131350","journal-title":"Urologe"},{"key":"1055_CR11","first-page":"233","volume":"26","author":"STIKO (St\u00e4ndige Impfkommission am Robert Koch-Institut)","year":"2018","unstructured":"STIKO (St\u00e4ndige Impfkommission am Robert Koch-Institut) (2018) Wissenschaftliche Begr\u00fcndung der HPV-Impfung f\u00fcr Jungen im Alter von 9 bis 14\u00a0Jahren. Epidemiol Bull 26:233\u2013250","journal-title":"Epidemiol Bull"},{"key":"1055_CR12","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00120-018-0807-z","volume":"57","author":"W B\u00fchmann","year":"2018","unstructured":"B\u00fchmann\u00a0W (2018) Impfen: Schutz f\u00fcr Jungen vor Genitalwarzen und Krebs durch Humane-Papillomviren-Infektion. Urologe 57:1499\u20131508","journal-title":"Urologe"},{"key":"1055_CR13","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1007\/s00120-018-0770-8","volume":"57","author":"P Schneede","year":"2018","unstructured":"Schneede\u00a0P (2018) Krankheitslast humaner Papillomviren der M\u00e4nner. HPV-Vorsorge wird M\u00e4nnersache. Urologe 57:1452\u20131456","journal-title":"Urologe"},{"key":"1055_CR14","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00120-018-0597-3","volume":"57","author":"P Schneede","year":"2018","unstructured":"Schneede\u00a0P, Schlenker\u00a0B (2018) Humane Papillomviren und Peniskarzinom. \u00dcberlegungen zu Pr\u00e4ventionsma\u00dfnahmen. Urologe 57:413\u2013417","journal-title":"Urologe"},{"key":"1055_CR15","unstructured":"https:\/\/www.g-ba.de\/bewertungsverfahren\/nutzenbewertung\/143\/\n                    \n                  . Zugegriffen: 05. April 2019"},{"key":"1055_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/1756287216681246","volume":"9","author":"A Hirbod-Mobarakeh","year":"2017","unstructured":"Hirbod-Mobarakeh\u00a0A, Gordan\u00a0HA, Zahiri\u00a0Z et al (2017) Specific immunotherapy in renal cancer: a\u00a0systemic review. Ther Adv Urol 9:45\u201358","journal-title":"Ther Adv Urol"},{"key":"1055_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MOU.0000000000000593","author":"MR Hassler","year":"2019","unstructured":"Hassler\u00a0MR, Shariat\u00a0SF, Soria\u00a0F (2019) Salvage therapeutic strategies for Bacillus Calmette-Guerin failure. Curr Opin Urol. \n                    https:\/\/doi.org\/10.1097\/MOU.0000000000000593","journal-title":"Curr Opin Urol"},{"key":"1055_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012112.pub2","author":"AR Shepherd","year":"2017","unstructured":"Shepherd\u00a0AR, Shepherd\u00a0E, Brook\u00a0NR (2017) Intravesical Bacillus Calmette-Guerin with interferon-alpha versus intravesical Bacillus Calmette-Guerin for treating non-muscle-invasive bladder cancer. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD012112.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"1055_CR19","first-page":"220","volume-title":"Der Impfkurs","author":"W Jilg","year":"2018","unstructured":"Jilg\u00a0W (2018) Die Impfung gegen Tuberkulose. In: Jilg\u00a0W (Hrsg) Der Impfkurs. Ecomed MEDIZIN, Landsberg am Lech, S\u00a0220\u2013221"},{"key":"1055_CR20","first-page":"314","volume":"99","author":"T Wilkins","year":"2019","unstructured":"Wilkins\u00a0T, Sams\u00a0R, Carpenter\u00a0M (2019) Hepatitis B: screening, prevention, diagnosis, and treatment. Am Fam Physician 99:314\u2013323","journal-title":"Am Fam Physician"},{"key":"1055_CR21","first-page":"61","volume-title":"Der Impfkurs","author":"W Jilg","year":"2018","unstructured":"Jilg\u00a0W (2018) Indikationsimpfungen. In: Jilg\u00a0W (Hrsg) Der Impfkurs. Ecomed MEDIZIN, Landsberg am Lech, S\u00a061\u201363"},{"key":"1055_CR22","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.3390\/ijerph15081618","volume":"15","author":"AI Beleni","year":"2018","unstructured":"Beleni\u00a0AI, Borgmann\u00a0S (2018) Mumps in the vaccination age: global epidemiology and the situation in Germany. Int J Environ Res Public Health 15:1618\u20131632","journal-title":"Int J Environ Res Public Health"},{"key":"1055_CR23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.euf.2018.07.034","volume":"5","author":"G Magistro","year":"2019","unstructured":"Magistro\u00a0G, Stief\u00a0CG (2019) Vaccine development for urinary tract infections: where do we stand? Eur Urol Focus 5:39\u201341","journal-title":"Eur Urol Focus"},{"key":"1055_CR24","unstructured":"https:\/\/www.rki.de\/SharedDocs\/FAQ\/Impfen\/AllgFr_Grunderkrankungen\/FAQ01.html\n                    \n                  . Zugegriffen: 05. April 2019"},{"key":"1055_CR25","first-page":"B-427","volume":"116","author":"C Betsch","year":"2019","unstructured":"Betsch\u00a0C, von Hirschhausen\u00a0E, Zylka-Menhorn\u00a0V (2019) Professionelle Gespr\u00e4chsf\u00fchrung \u2013 wenn Reden Gold wert ist. Dtsch Arztebl 116:B-427\u2013B-433","journal-title":"Dtsch Arztebl"},{"key":"1055_CR26","first-page":"141","volume":"e20170498","author":"CM Rand","year":"2018","unstructured":"Rand\u00a0CM, Schaffer\u00a0SJ, Dhepyasuwan\u00a0N et\u00a0al (2018) Provider communication, prompts, and feedback to improve HPV vaccination rates in resident clinics. Pediatr Electron Pages 141:e20170498","journal-title":"Electron"},{"key":"1055_CR27","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.0016","author":"AF Dempsey","year":"2018","unstructured":"Dempsey\u00a0AF, Pyrznawoski\u00a0J, Lockhart\u00a0S et\u00a0al (2018) Effect of a\u00a0health care professional communication training intervention on adolescent human papillomavirus vaccination. A cluster randomized clinical trial. JAMA Pediatr. \n                    https:\/\/doi.org\/10.1001\/jamapediatrics.2018.0016","journal-title":"JAMA Pediatr"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-019-01055-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-019-01055-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-019-01055-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T01:10:02Z","timestamp":1603761002000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-019-01055-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,28]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1055"],"URL":"https:\/\/doi.org\/10.1007\/s00120-019-01055-1","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,28]]},"assertion":[{"value":"28 October 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>P.\u00a0Schneede<\/b>: A.\u00a0Finanzielle Interessen: Als eingeladener Referent verschiedener Fort- und Weiterbildungsveranstaltungen wurden entweder Reise- und \u00dcbernachtungskosten erstattet oder zus\u00e4tzlich \u00fcbliche Honorare in H\u00f6he von 500\u20131000\u202f\u20ac von den Kongressveranstaltern gezahlt. S\u00e4mtliche Honorare gingen auf ein von der Klinikumsverwaltung des Klinikums Memmingen gef\u00fchrtes Drittmittelkonto. Da Kongressveranstalter in der Regel wechseln, wurde lediglich von der Paul-Ehrlich-Gesellschaft (PEG) als Kongressveranstalter des HPV-Management-Forums, einer AG der PEG, regelm\u00e4\u00dfig f\u00fcr j\u00e4hrliche Fort- und Weiterbildungen ein Honorar in H\u00f6he von 500\u202f\u20ac neben Reisekosten erstattet. Insgesamt wurden Honorare unter 10.000\u202f\u20ac in den letzten 5\u00a0Jahren eingenommen. Honorierungen von Industrie oder Wirtschaft in direktem Vertragsverh\u00e4ltnis wurden stets abgelehnt. \u2013 B.\u00a0Nichtfinanzielle Interessen: Chefarzt der Urologie des Klinikums Memmingen, 87700 Memmingen, Bismarckstra\u00dfe\u00a023 |\u00a0Lehrbeauftragter des Lehrkrankenhauses der LMU M\u00fcnchen |\u00a0Leiter des DKG-zertifizierten Prostatakarzinomzentrums sowie des zertifizierten Laserzentrums am Klinikum Memmingen |\u00a0Mitgliedschaften: DGU, EAU, PEG-HPV-MF, DSTIG.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}